
Cris Loiren Rodriguez
Supervisory Patent Examiner (ID: 13791, Phone: (571)272-4964 , Office: P/3732 )
| Most Active Art Unit | 3763 |
| Art Unit(s) | 3306, 3772, 1612, 3734, 3633, 2763, 3763, 3732, 3783 |
| Total Applications | 1175 |
| Issued Applications | 574 |
| Pending Applications | 326 |
| Abandoned Applications | 279 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8797279
[patent_doc_number] => 08436148
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-05-07
[patent_title] => 'Antibodies against interleukin-18 binding protein, their preparation and use'
[patent_app_type] => utility
[patent_app_number] => 12/511756
[patent_app_country] => US
[patent_app_date] => 2009-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 32
[patent_no_of_words] => 17939
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12511756
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/511756 | Antibodies against interleukin-18 binding protein, their preparation and use | Jul 28, 2009 | Issued |
Array
(
[id] => 5551792
[patent_doc_number] => 20090285778
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-19
[patent_title] => 'USE OF INTERLEUKIN-19 TO TREAT CERVICAL CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/508812
[patent_app_country] => US
[patent_app_date] => 2009-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6154
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0285/20090285778.pdf
[firstpage_image] =>[orig_patent_app_number] => 12508812
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/508812 | USE OF INTERLEUKIN-19 TO TREAT CERVICAL CANCER | Jul 23, 2009 | Abandoned |
Array
(
[id] => 6306637
[patent_doc_number] => 20100069343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-18
[patent_title] => 'Methods of predicting steroid responsiveness with Il-1RII'
[patent_app_type] => utility
[patent_app_number] => 12/460381
[patent_app_country] => US
[patent_app_date] => 2009-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8907
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20100069343.pdf
[firstpage_image] =>[orig_patent_app_number] => 12460381
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/460381 | Methods of predicting steroid responsiveness with Il-1RII | Jul 16, 2009 | Abandoned |
Array
(
[id] => 6080135
[patent_doc_number] => 20110142851
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-16
[patent_title] => 'IL6 Immunotherapeutics'
[patent_app_type] => utility
[patent_app_number] => 13/001084
[patent_app_country] => US
[patent_app_date] => 2009-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 29795
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20110142851.pdf
[firstpage_image] =>[orig_patent_app_number] => 13001084
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/001084 | Antagonists of IL-6 | Jul 1, 2009 | Issued |
Array
(
[id] => 5558234
[patent_doc_number] => 20090269811
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-29
[patent_title] => 'IL-1 RELATED POLYPEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 12/496363
[patent_app_country] => US
[patent_app_date] => 2009-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 60882
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20090269811.pdf
[firstpage_image] =>[orig_patent_app_number] => 12496363
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/496363 | IL-1 RELATED POLYPEPTIDES | Jun 30, 2009 | Abandoned |
Array
(
[id] => 4525178
[patent_doc_number] => 07951916
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-05-31
[patent_title] => 'Il-1 related polypeptides'
[patent_app_type] => utility
[patent_app_number] => 12/496197
[patent_app_country] => US
[patent_app_date] => 2009-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 26
[patent_no_of_words] => 60903
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/951/07951916.pdf
[firstpage_image] =>[orig_patent_app_number] => 12496197
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/496197 | Il-1 related polypeptides | Jun 30, 2009 | Issued |
Array
(
[id] => 5367142
[patent_doc_number] => 20090304701
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'ANTIBODIES BINDING IL-1 RELATED POLYPEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 12/495633
[patent_app_country] => US
[patent_app_date] => 2009-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 60903
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0304/20090304701.pdf
[firstpage_image] =>[orig_patent_app_number] => 12495633
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/495633 | Antibodies binding IL-1 related polypeptides | Jun 29, 2009 | Issued |
Array
(
[id] => 8421577
[patent_doc_number] => 08278065
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-10-02
[patent_title] => 'Polynucleotides encoding anti-GD2 antibodies'
[patent_app_type] => utility
[patent_app_number] => 12/494631
[patent_app_country] => US
[patent_app_date] => 2009-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 30
[patent_no_of_words] => 32713
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12494631
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/494631 | Polynucleotides encoding anti-GD2 antibodies | Jun 29, 2009 | Issued |
Array
(
[id] => 4450870
[patent_doc_number] => 07964193
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-06-21
[patent_title] => 'Antibodies against interleukin-1 β'
[patent_app_type] => utility
[patent_app_number] => 12/456660
[patent_app_country] => US
[patent_app_date] => 2009-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 28800
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/964/07964193.pdf
[firstpage_image] =>[orig_patent_app_number] => 12456660
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/456660 | Antibodies against interleukin-1 β | Jun 18, 2009 | Issued |
Array
(
[id] => 5551789
[patent_doc_number] => 20090285775
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-19
[patent_title] => 'TREATMENT OF WOUNDS USING IL-17B'
[patent_app_type] => utility
[patent_app_number] => 12/484947
[patent_app_country] => US
[patent_app_date] => 2009-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8172
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0285/20090285775.pdf
[firstpage_image] =>[orig_patent_app_number] => 12484947
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/484947 | TREATMENT OF WOUNDS USING IL-17B | Jun 14, 2009 | Abandoned |
Array
(
[id] => 7795383
[patent_doc_number] => 08124089
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-02-28
[patent_title] => 'Anti-human IL-21 monoclonal antibodies'
[patent_app_type] => utility
[patent_app_number] => 12/483098
[patent_app_country] => US
[patent_app_date] => 2009-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 46377
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 153
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/124/08124089.pdf
[firstpage_image] =>[orig_patent_app_number] => 12483098
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/483098 | Anti-human IL-21 monoclonal antibodies | Jun 10, 2009 | Issued |
Array
(
[id] => 6614384
[patent_doc_number] => 20100310502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-09
[patent_title] => 'Method of treating local infections in mammals'
[patent_app_type] => utility
[patent_app_number] => 12/455929
[patent_app_country] => US
[patent_app_date] => 2009-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5392
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0310/20100310502.pdf
[firstpage_image] =>[orig_patent_app_number] => 12455929
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/455929 | Method of treating local infections in mammals | Jun 8, 2009 | Abandoned |
Array
(
[id] => 5972471
[patent_doc_number] => 20110152171
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-23
[patent_title] => 'HISTAMINE BINDING PROTEIN'
[patent_app_type] => utility
[patent_app_number] => 12/993815
[patent_app_country] => US
[patent_app_date] => 2009-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 14408
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20110152171.pdf
[firstpage_image] =>[orig_patent_app_number] => 12993815
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/993815 | HISTAMINE BINDING PROTEIN | May 20, 2009 | Abandoned |
Array
(
[id] => 6039390
[patent_doc_number] => 20110092439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-21
[patent_title] => 'METHOD OF PROMOTING WOUND HEALING'
[patent_app_type] => utility
[patent_app_number] => 12/992626
[patent_app_country] => US
[patent_app_date] => 2009-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 14439
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20110092439.pdf
[firstpage_image] =>[orig_patent_app_number] => 12992626
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/992626 | METHOD OF PROMOTING WOUND HEALING | May 12, 2009 | Abandoned |
Array
(
[id] => 6595707
[patent_doc_number] => 20100062487
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-11
[patent_title] => 'Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses'
[patent_app_type] => utility
[patent_app_number] => 12/387959
[patent_app_country] => US
[patent_app_date] => 2009-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 366
[patent_figures_cnt] => 366
[patent_no_of_words] => 112084
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12387959
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/387959 | Methods for identifying compounds which bind to TANGO294 | May 7, 2009 | Issued |
Array
(
[id] => 5397337
[patent_doc_number] => 20090317400
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-24
[patent_title] => 'Anti-IL 17A/IL-17F Cross-Reactive Antibodies and Methods of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/435494
[patent_app_country] => US
[patent_app_date] => 2009-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34249
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20090317400.pdf
[firstpage_image] =>[orig_patent_app_number] => 12435494
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/435494 | Anti-IL 17A/IL-17F Cross-Reactive Antibodies and Methods of Use Thereof | May 4, 2009 | Abandoned |
Array
(
[id] => 10635686
[patent_doc_number] => 09353180
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-31
[patent_title] => 'Method of treatment by the administration of inhibitors of GM-CSF and IL-17'
[patent_app_type] => utility
[patent_app_number] => 12/990006
[patent_app_country] => US
[patent_app_date] => 2009-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 21389
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12990006
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/990006 | Method of treatment by the administration of inhibitors of GM-CSF and IL-17 | Apr 27, 2009 | Issued |
Array
(
[id] => 5464996
[patent_doc_number] => 20090325196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-31
[patent_title] => 'LEVELS OF BCMA PROTEIN EXPRESSION ON B CELLS AND USE IN DIAGNOSTIC METHODS'
[patent_app_type] => utility
[patent_app_number] => 12/429502
[patent_app_country] => US
[patent_app_date] => 2009-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 20364
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0325/20090325196.pdf
[firstpage_image] =>[orig_patent_app_number] => 12429502
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/429502 | LEVELS OF BCMA PROTEIN EXPRESSION ON B CELLS AND USE IN DIAGNOSTIC METHODS | Apr 23, 2009 | Abandoned |
Array
(
[id] => 7499453
[patent_doc_number] => 20110262443
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-27
[patent_title] => 'Epitopes Of Il-17a And Il-17f And Antibodies Specific Thereto'
[patent_app_type] => utility
[patent_app_number] => 12/989373
[patent_app_country] => US
[patent_app_date] => 2009-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 17788
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0262/20110262443.pdf
[firstpage_image] =>[orig_patent_app_number] => 12989373
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/989373 | Antibodies specific to IL-17A and IL-17F | Apr 21, 2009 | Issued |
Array
(
[id] => 6348894
[patent_doc_number] => 20100021496
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-28
[patent_title] => 'METHODS, KITS, AND ANTIBODIES FOR QUANTITATIVE DETERMINATION OF PARATHYROID HORMONE MOLECULES WITH INTACT C-TERMINUS'
[patent_app_type] => utility
[patent_app_number] => 12/423702
[patent_app_country] => US
[patent_app_date] => 2009-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 13115
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20100021496.pdf
[firstpage_image] =>[orig_patent_app_number] => 12423702
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/423702 | METHODS, KITS, AND ANTIBODIES FOR QUANTITATIVE DETERMINATION OF PARATHYROID HORMONE MOLECULES WITH INTACT C-TERMINUS | Apr 13, 2009 | Abandoned |